Heart failure with reduced ejection fraction: differences between atrial fibrillation and sinus rhythm
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251626Keywords:
Atrial fibrillation, Heart failure, Reduced ejection fraction, Sinus rhythmAbstract
Background: Atrial fibrillation (AF) is a common comorbidity in heart failure with reduced ejection fraction (HFrEF), with prevalence ranging from 10% to 60%. While AF is generally associated with increased mortality in HF, its impact on HFrEF outcomes remains uncertain. This study evaluates clinical, laboratory and echocardiographic differences between HFrEF patients with and without AF.
Methods: This study included 91 patients (Left ventricular ejection fraction<50%) admitted to Grodno State Cardiological Centre from January to November 2024. Patients were divided into two groups: 57 (63%) with AF (paroxysmal or persistent) and 34 (37%) with sinus rhythm (SR). Clinical, laboratory and echocardiographic data were analysed using STATISTICA 12.0.
Results: AF patients had higher BMI (p=0.005) and obesity prevalence (62% vs 26%, p=0.001). Hypertension and diabetes rates were similar, but SR patients had more stable angina (53% vs 34%, p=0.03) and prior myocardial infarction (44% vs 26%, p=0.048). AF patients showed worse renal function (higher urea, creatinine and lower eGFR). Echocardiography revealed larger left (p=0.03) and right atria (p=0.017) in AF, while SR patients had a higher contractility index (p=0.032).
Conclusions: HFrEF patients with SR more often had ischemic cardiomyopathy, while those with AF had a dilated or mixed origin, as reflected in atrial size and contractility differences.
Metrics
References
Rasool MH, Persand D, Salam S. The dilemma of use of anticoagulation in patients with heart failure with reduced ejection fraction and sinus rhythm: a case report and literature review. cureus. 2023 feb 20;15(2):45-8.
Aldli M, Alsultan M, Alkhatib M. The clinical classification of patients with acute heart failure at emergency department and its relation with management and outcome: a cross sectional study from Syria. BMC Cardiovasc Disord. 2025;25(1):194. DOI: https://doi.org/10.1186/s12872-025-04644-5
Taha AM, Hendi NI, Elwekel AB Cryoballoon ablation for atrial fibrillation in patients with heart failure and reduced left ventricular ejection fraction: A systematic review and meta-analysis. Clin Cardiol. 2024;47(1):38-41. DOI: https://doi.org/10.1002/clc.24177
Jin X, Nauta JF, Hung CL. Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis. Heart Fail Rev. 2022;27(5):1933-55. DOI: https://doi.org/10.1007/s10741-021-10204-8
Vecchio N, Ripa L, Orosco A. Atrial Fibrillation in Heart Failure Patients with Preserved or Reduced Ejection Fraction. Prognostic significance of Rhythm control strategy with Catheter Ablation. J Atr Fibrillation. 2019;11(5):2128. DOI: https://doi.org/10.4022/jafib.2128
Nagatomo Y, Yoshikawa T, Okamoto H, Kitabatake A, Hori M. Differential response to heart rate reduction by carvedilol in heart failure and reduced ejection fraction between sinus rhythm and atrial fibrillation insight from J-CHF study. Circ Rep. 2020;2(3):143-51. DOI: https://doi.org/10.1253/circrep.CR-20-0008
Mboweni N, Maseko M, Tsabedze N. Heart failure with reduced ejection fraction and atrial fibrillation: a Sub-Saharan African perspective. ESC Heart Fail. 2023;10(3):1580-96. DOI: https://doi.org/10.1002/ehf2.14332
Al-Kaisey AM, Kalman JM. Obesity and Atrial Fibrillation: Epidemiology, Pathogenesis and Effect of Weight Loss. Arrhythm Electrophysiol Rev. 2021;10(3):159-64. DOI: https://doi.org/10.15420/aer.2021.36
Shu H, Cheng J, Li N. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance. Cardiovasc Diabetol. 2023;22(1):64. DOI: https://doi.org/10.1186/s12933-023-01913-5
Gallo G, Savoia C. Hypertension and Heart Failure: From Pathophysiology to Treatment. Int J Mol Sci. 2024;25(12):69-71. DOI: https://doi.org/10.3390/ijms25126661
Rosano GM, Vitale C, Seferovic P. Heart Failure in Patients with Diabetes Mellitus. Card Fail Rev. 2017;3(1):52-5. DOI: https://doi.org/10.15420/cfr.2016:20:2
Kenny HC, Abel ED. Heart Failure in Type 2 Diabetes Mellitus. Circ Res. 2019;124(1):121-41. DOI: https://doi.org/10.1161/CIRCRESAHA.118.311371
Violi F, Soliman EZ, Pignatelli P, Pastori D. Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms. J Am Heart Assoc. 2016;5(5):56. DOI: https://doi.org/10.1161/JAHA.116.003347
Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis. Eur J Prev Cardiol. 2017;24(14):1555-66. DOI: https://doi.org/10.1177/2047487317715769
Soliman EZ, Safford MM, Muntner P. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174(1):107-14. DOI: https://doi.org/10.1001/jamainternmed.2013.11912
Damman K, Testani JM. The kidney in heart failure: an update. Eur Heart J. 2015;36(23):1437-44. DOI: https://doi.org/10.1093/eurheartj/ehv010
Gadde S, Kalluru R, Cherukuri SP, Chikatimalla R, Dasaradhan T, Koneti J. Atrial Fibrillation in Chronic Kidney Disease: An Overview. Cureus. 2022;14(8):27753. DOI: https://doi.org/10.7759/cureus.27753
van de Vegte YJ, Siland JE, Rienstra M, van der Harst P. Atrial fibrillation and left atrial size and function: a Mendelian randomization study. Sci Rep. 2021;11(1):8431. DOI: https://doi.org/10.1038/s41598-021-87859-8
Downloads
Published
How to Cite
Issue
Section
